Elsevier

Immunobiology

Volume 191, Issue 1, August 1994, Pages 38-51
Immunobiology

Modulation of Adhesion Molecule Expression on Endothelial Cells by Verapamil and Other Ca++ Channel Blockers

https://doi.org/10.1016/S0171-2985(11)80266-4Get rights and content

Abstract

Cytokine-induced expression of adhesion molecules on leukocytes and endothelial cells (EC) is a crucial point in the process of organ transplant rejection. It has been shown that protein kinase C (PKC) is involved in this activation process. Verapamil and other calcium channel blockers seem to possess immunosuppressive qualities in vivo and in vitro; some authors suggested that this is due to PKC- or calmodulin-antagonism. Thus our objectives were to further investigate the second-messenger systems involved in the stimulation of EC and to analyze whether the beneficial influence of calcium channel blockers on the outcome of transplantation is due to impaired expression of adhesion molecules on EC..

Our results, obtained in an in vitro model using human umbilical vein EC, show that IL-1-induced expression of intercellular adhesion molecule-1 (ICAM-1) is in part mediated by PKC and that parallel activation of calmodulin is required. Expression of ICAM-1 was reduced to 38.5% by PKC-inhibitor H7 and to 77.2% by calmodulininhibitor W7. In addition, data on the intracellular events in TNF-α-induced expression of vascular cell adhesion molecule-1 (VCAM-1) is presented, showing that both PKC and, to a higher extent, calmodulin, are involved in this process. Expression of VCAM-1 was reduced to 63.7% by H7 and to 27.7% by W7. IL-1-induced expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) is PKC-dependent but insensitive to blocking of calmodulin.

Though activation of adhesion molecule expression utilizes PKC and/or calmodulin as second-messenger pathways the investigated calcium channel blockers verapamil (R- and S-enantiomers), diltiazem and Ro 40-5967 failed to inhibit adhesion molecule expression.Surprisingly, higher concentrations of verapamil (> 12.5 μ/ml) or Ro 40-5967 (5 μg/ml) significantly enhanced IL-1-induced expression of ELAM-1. ICAM-1-expression was also enhanced by verapamil, but not by Ro 40-5967 or diltiazem. This enhancement was only seen if verapamil was added maximally one hour after the cytokine stimulus indicating that transcriptional modulation is responsible for the observed effects. Our findings indicate that calcium channel blockers have an immunomodulating effect independent of adhesion molecule expression.

References (29)

  • G. Baumann

    Molecular mechanisms of immunosuppressive agents

    Transplant. Proc. 24, No 4, Suppl

    (1992)
  • I. Dawidson et al.

    Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil

    Transplantation

    (1989)
  • B.F. Palmer et al.

    Improved outcome of cadaveric renal transplantation due to calcium channel blockers

    Transplantation

    (1991)
  • M. Suthanthiran et al.

    Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation

    Transplantation

    (1993)
  • Cited by (14)

    • Impact of heparin bonding on pediatric cardiopulmonary bypass: A prospective randomized study

      2000, Annals of Thoracic Surgery
      Citation Excerpt :

      Thus, use of HBCPB did not affect IL-6 production in these patients. IL-1 is an endogenous pyrogen, which results in the production of adhesion molecules [25] and increases the synthesis of other inflammatory mediators. Serum IL-1 was not elevated in either patient group during or after CPB.

    • Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells

      2006, Graefe's Archive for Clinical and Experimental Ophthalmology
    View all citing articles on Scopus
    a

    Dr. Nils P.Hailer, Klinik für Allgemein- and Abdominalchirurgie, Transplantationsimmunologisches Labor, Eg7, Haus 23A, Klinikum der Johann-Wolfgang-GoetheUniversität, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany

    View full text